Astellas chipped in as UC Berkeley spinout Iota Biosciences captured $15m in a series A round that will fund the entry of its neural dust technology into preclinical testing.

The database software provider reportedly boosted its total funding to $95m in a Temenos-led round that included existing investor Dassault Systèmes.

Promethera Biosciences has received $11.3m in series D funding from Itochu and $16.6m in a convertible debt round backed by Sosei.

The financial analysis software provider, which counts SIG as an investor, has secured series B funding to take its overall funding to date to $60m.

The Baidu-backed acoustics technology developer has raised money in an Addor Capital-led round that reportedly boosted its overall funding to $86m.

Aflac has invested $20m in the life insurance portal in connection with a reinsurance services agreement, following a $50m series A round in 2017.

The blood-testing device producer, which counts Access Industries and Haisco as investors, has added $28m to its coffers.

Bristol-Myers Squibb and PureTech Health both backed a round that followed the $50m that PureTech spinoff Vedanta secured in 2016.

The Flipkart-backed shipping services platform has raised additional capital from Accel and Sands Capital, taking its total funding to approximately $141m.

Celgene, Taikang and WuXi AppTec have all taken part in a series B round for Antengene, which is working on treatments for cancers with a focus on Southeast and East Asia.